Menora Mivtachim Holdings LTD Increased Mylan Nv (MYL) Stake by $198.67 Million; Shares Declined

June 29, 2018 - By Joshua Cleveland

Mylan N.V. (NASDAQ:MYL) Corporate LogoDuring Q1 2018 the big money sentiment decreased to 1. That’s change of 2.00, from 2017Q4’s 3. 1 investors sold all, 2 reduced holdings as MYL ratio worsened. 0 rose holdings while 3 funds amassed holdings. Funds hold 190,596 shares thus 34.92% less from 2017Q4’s 292,846 shares. The California-based Gemmer Asset Ltd Liability has invested 0% in Mylan N.V. (NASDAQ:MYL). Eqis Management invested 0.01% of its capital in Mylan N.V. (NASDAQ:MYL). Van Hulzen Asset Management Limited Liability Corp accumulated 30,685 shs. Gulf International Bankshares (Uk) holds 139,000 shs or 0.07% of its capital. Vantage Limited Liability has 337 shs.

In 2018Q1 SEC form is reported Menora Mivtachim Holdings Ltd’s holdings in Mylan Nv (MYL) which was rose by 219.08%. 4.85M shares were bought by Menora Mivtachim Holdings Ltd as the company’s stock declined 5.74% with the market. The major pharmaceuticals company at the end of 2018Q1 was valued at $290.56M. It’s up from 2.21 million at the end of the previous reported quarter. Now it had 7.06 million shares held by the institutional investor . Mylan Nv has $18.91 billion market cap. The stock increased 0.99% or $0.36 during the last trading session, touching $36.69.Currently Mylan N.V. is downtrending after 1.13% change in last June 29, 2017. MYL has 762,952 shares volume. MYL underperformed the S&P 500 by 13.70%.

About $3.16B US Long portfolio Menora Mivtachim Holdings Ltd manages. It decreased its stake in Mellanox Technologies Ltd (NASDAQ:MLNX) by 92,600 shares to 2.04 million shares, valued at $148.72M in 2018Q1, according to the filing. For a total of 300,950 shares it reduced its holding in Paypal Hldgs Inc by 90,200 shares in the quarter, and has cut its stake in Te Connectivity Ltd (NYSE:TEL).

Another two news for Mylan N.V. (NASDAQ:MYL) were briefly posted by: Streetinsider.com on June 18, 2018 with title “Mylan (MYL) Announces Launch of Generic Angiomax Injection”. The other Seekingalpha.com‘s article was titled “Mylan: A Margin Of Safety Case Study” and posted on June 04, 2018.

Mylan N.V. (NASDAQ:MYL) Ratings Coverage

In total 15 analysts cover Mylan (NASDAQ:MYL). “Buy” rating has 11, “Sell” are 0, while 4 are “Hold”. (NASDAQ:MYL) has 73% bullish analysts. 20 are the (NASDAQ:MYL)’s ratings reports on 29 Jun 2018 according to StockzIntelligence Inc. On Thursday, January 18 the rating was maintained by Mizuho with “Buy”. On Thursday, January 11 the rating was upgraded by Goldman Sachs to “Buy”. On Thursday, April 12 the firm has “Buy” rating by Mizuho given. On Monday, April 9 the rating was maintained by Morgan Stanley with “Buy”. The stock rating was maintained by Wells Fargo with “Market Perform” on Thursday, May 31. On Tuesday, March 6 the stock of Mylan N.V. (NASDAQ:MYL) has “Overweight” rating given by Morgan Stanley. On Thursday, January 4 the firm has “Buy” rating given by Citigroup. On Tuesday, May 29 the firm has “Neutral” rating given by Bank of America. In Thursday, January 25 report Susquehanna maintained the stock with “Buy” rating. On Tuesday, April 3 the stock has “Hold” rating by RBC Capital Markets.

Mylan N.V. (NASDAQ:MYL) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.